EC5026

pM oral sEH epoxide hydrolase inhibitor

completed Ph. I HV study + in animal health

epoxide-opening transition-state mimic

J. Med. Chem., Feb. 7, 2021

EicOsis Human Health Inc., Davis, CA

8. The EicOsis oral soluble epoxide hydrolase (sEH) inhibitor, EC5026, is a compound currently intended as a non-opioid analgesic and anti-inflammatory agent. It recently completed a Ph. I study…


 become a member to continue reading

Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.

  • Stay up-to-date and save more time with exclusive members-only content
  • On-board new team members with educational content and case studies
  • Generate ideas and discussion with easy-to-read slide decks
  • Generate ideas and discussion with easy-to-read slide decks